Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage
Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage have?
Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage has 4 citations in the OpenAlex counts ScholarIQ stores.
When was Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage published?
Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage has 2021 year in the ScholarIQ index.
What is the open-access status of Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage?
Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage has diamond oa status in the ScholarIQ index.
What is the DOI of Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage?
The DOI for Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage is on the source record.
What is the PMID of Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage?
The PMID for Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage is on the source record.
What is the OpenAlex record for Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage?
The OpenAlex for Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage is on the source record.